Search company, investor...
WaveForm Diabetes company logo

WaveForm Diabetes

Founded Year



Loan - II | Alive

Total Raised


Last Raised

$680K | 3 yrs ago

About WaveForm Diabetes

WaveForm Diabetes is delivering connected diabetes solutions that empower people to live healthier lives.

Headquarters Location

27700 SW 95th Ave

Wilsonville, Oregon, 97070,

United States


Missing: WaveForm Diabetes's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: WaveForm Diabetes's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

Research containing WaveForm Diabetes

Get data-driven expert analysis from the CB Insights Intelligence Unit.

CB Insights Intelligence Analysts have mentioned WaveForm Diabetes in 2 CB Insights research briefs, most recently on Apr 22, 2020.

Expert Collections containing WaveForm Diabetes

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

WaveForm Diabetes is included in 6 Expert Collections, including Medical Devices.


Medical Devices

11,848 items

Companies developing medical devices (per the IMDRF's definition of "medical device"). Includes software, lab-developed tests (LDTs), and combination products. *Columns updated as regularly as possible.



2,046 items


Digital Health

13,118 items

Technologies, platforms, and systems that engage consumers for lifestyle, wellness, or health-related purposes; capture, store, or transmit health data; and/or support life science and clinical operations. (DiME, DTA, HealthXL, & NODE.Health)



2,854 items

Companies developing, offering, or using electronic and telecommunication technologies to facilitate the delivery of health & wellness services from a distance. *Columns updated as regularly as possible; priority given to companies with the most and/or most recent funding.


Health Monitoring & Diagnostics

1,544 items

Companies developing technology to facilitate near-patient and point-of-care (POC) in vitro diagnostic testing. Companies tagged as #NearPatient&POCTesting


Health IT

8,881 items

WaveForm Diabetes Patents

WaveForm Diabetes has filed 1 patent.

The 3 most popular patent topics include:

  • Analytical chemistry
  • Electrochemistry
  • Diabetes
patents chart

Application Date

Grant Date


Related Topics




Fluid dynamics, Electrochemistry, Electrodes, Capacitors, Nondestructive testing


Application Date


Grant Date



Related Topics

Fluid dynamics, Electrochemistry, Electrodes, Capacitors, Nondestructive testing



Latest WaveForm Diabetes News

Diabetes Devices Market Research Report by Type, by End Use, by Distribution, by Region - Global Forecast to 2027 - Cumulative Impact of COVID-19

Jan 21, 2022

Use, by Distribution, by Region - Global Forecast to 2027 - Cumulative Impact of COVID-19" - The Global Diabetes Devices Market size was estimated at USD 25.91 billion in 2020 and expected to reach USD 27.75 billion in 2021, at a CAGR 7.46% to reach USD 42.89 billion by 2027. Market Statistics: The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2019 are considered historical years, 2020 as the base year, 2021 as the estimated year, and years from 2022 to 2027 are considered the forecast period. Market Segmentation & Coverage: This research report categorizes the Diabetes Devices to forecast the revenues and analyze the trends in each of the following sub-markets: Based on Type, the market was studied across Blood Glucose Monitoring and Insulin Delivery Devices. The Blood Glucose Monitoring is further studied across Continuous Blood Glucose Monitoring Devices, Lancets/ Lancing Devices, Self-monitoring Blood Glucose Devices, and Test Strip/ Test Papers. The Insulin Delivery Devices is further studied across Jet Injectors, Pens, Pumps, and Syringes. Based on End Use, the market was studied across Diagnostic Centers, Home Care, and Hospitals. Based on Distribution, the market was studied across Diabetes Clinics, Hospital Pharmacies, Online Pharmacies, and Retail Pharmacies. Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, and Thailand. The Europe, Middle East & Africa is further studied across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom. Cumulative Impact of COVID-19: COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market. Competitive Strategic Window: The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period. FPNV Positioning Matrix: The FPNV Positioning Matrix evaluates and categorizes the vendors in the Diabetes Devices Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape. Market Share Analysis: The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits. Competitive Scenario: The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor’s strength and weakness thereby, providing insights to enhance product and service. Company Usability Profiles: The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Diabetes Devices Market, including Abbott Laboratories, Acon Laboratories, Inc., Agamatrix Holdings Llc, Arkray, Inc, Ascensia Diabetes Care Holdings AG, B Braun Melsungen AG, Bayer Corporation, Becton, Dickinson and Company, Bionime Corporation, Dexcom Inc., Dr. Morepen, F Hoffmann-La Roche AG, Insulet Corporation, LifeScan, Inc, Medtronic PLC, Microgene Diagnostic Systems Pvt. Ltd., Novo Nordisk A/s, Rossmax International Ltd., Sanofi, SD BioSensor Inc., Sinocare, InC., Terumo Corporation, Valeritas Holdings Inc., and Ypsomed Holding AG. The report provides insights on the following pointers: 1. Market Penetration: Provides comprehensive information on the market offered by the key players 2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets 3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments 4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players 5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments The report answers questions such as: 1. What is the market size and forecast of the Global Diabetes Devices Market? 2. What are the inhibiting factors and impact of COVID-19 shaping the Global Diabetes Devices Market during the forecast period? 3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Diabetes Devices Market? 4. What is the competitive strategic window for opportunities in the Global Diabetes Devices Market? 5. What are the technology trends and regulatory frameworks in the Global Diabetes Devices Market? 6. What is the market share of the leading vendors in the Global Diabetes Devices Market? 7. What modes and strategic moves are considered suitable for entering the Global Diabetes Devices Market?

WaveForm Diabetes Web Traffic

Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

WaveForm Diabetes Rank

WaveForm Diabetes Frequently Asked Questions (FAQ)

  • When was WaveForm Diabetes founded?

    WaveForm Diabetes was founded in 2001.

  • Where is WaveForm Diabetes's headquarters?

    WaveForm Diabetes's headquarters is located at 27700 SW 95th Ave, Wilsonville.

  • What is WaveForm Diabetes's latest funding round?

    WaveForm Diabetes's latest funding round is Loan - II.

  • How much did WaveForm Diabetes raise?

    WaveForm Diabetes raised a total of $117.34M.

  • Who are the investors of WaveForm Diabetes?

    Investors of WaveForm Diabetes include Paycheck Protection Program, Perceptive Advisors, Prospect Capital Corporation, Collaborative Seed & Growth Partners, Ferrer Freeman & Company and 4 more.

  • Who are WaveForm Diabetes's competitors?

    Competitors of WaveForm Diabetes include Biolinq, Senseonics, Biosense Technologies (India), LifeScan, Integrity Applications and 7 more.

Compare WaveForm Diabetes to Competitors

Pacific Diabetes Technologies

Pacific Diabetes Technologies develops a hollow glucose sensor that allows insulin infusion and continuous glucose monitoring.

LifeScan Logo

LifeScan, a maker of blood glucose monitoring products, is dedicated to improving the quality of life for people with diabetes. More diabetes specialist and pharmacists recommend LifeScan systems than any other brand. Every day, more than three million people rely on LifeScan systems for simple testing and accurate results.

Diafyt MedTech Logo
Diafyt MedTech

Diafyt MedTech is a developer of software for automated diabetes therapy that predicts the amount and timing of insulin necessary to control blood sugar levels. The company is developing a software-supported therapy with which the patient positively influences his illness in such a way that a side-effect-free, healthy similar lifestyle is possible. In addition to the automatic bolus calculation, this includes influencing the patient's diet and fitness in order to achieve an overall improvement in the health picture (digital diabetes therapy). The company's aim is to mathematically reproduce the diabetic function of the human pancreas in such a way that a fully automatic insulin dose is made possible in the sense of an artificial pancreas.

Withings Logo

Withings creates smart products and apps to help people across the world take care of their health and well-being. By extending the capabilities of an object through network resources, Withings provides access to computing and storage facility at no extra cost, turning objects into smart connected devices.

Intuity Medical Logo
Intuity Medical

Intuity Medical seeks to simplify diabetes management for persons living with diabetes. The company is developing a blood glucose monitoring system designed to make testing easy, convenient and discreet.

TytoCare Logo

TytoCare connects people to clinicians to provide virtual home examinations and diagnosis solutions. TytoCare's solutions are designed to enable a comprehensive medical exam with clinicians, from any location.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.